Henry S. Sauala, MD Adhytya Pratama, MD INTRODUCTION Case A 45 years-old gentleman visiting ED with chief complaint of chest pain 14 hours prior to admission. The pain characteristic was consistent to MI. The night before, he initially sought no medical attention and rest at his home. Afterwards in the morning, the pain was felt again with the scale of 8/10+ dyspnea, and his wife took him to ED. Risk Factor: Active Smoker, Dyslipidemia. PEx: 110/60 mmHg; 100 bpm; 22x/m; 36,9OC Gallop S3 (+), Rales: --+/--+; JVD R+3 ED EKG His ECG showed anterior extensive MI, MI algorithm activated. Working Dx: Acute anterior STEMI late onset Killip 2, Acute HF Rx: Aspirin 160mg (chewed), Clopidogrel 300mg, ISDN 5 mg SL, simvaStatin 40mg orally We continued with anticoagulation by giving Fondaparinux. We decided to perform fibrinolysis with 1.5 millions IU of intravenous Streptokinase. In the process there were bigeminy VPC, no other major complications of lytics were observed. Afterwards the pain was decreasing to 4/10 and ECG evolved to Q waves. Then in his next 24 hours, the pain was resolved to 0/10. The third day of hospitalization, the echo was evaluated. 1-H post lytics EKG TTE echo showed LVEF of 46% with RWMA according to his infarcted areas. and he was discharged home with dual antiplatelet, statin, furosemide, ACE-I, and beta blocker. Discussions Though no mortality benefit was demonstrated in the LATE and EMERAS trials when fibrinolytic was routinely administered to patients between 12-24 hours, we believe that it is still reasonable to consider fibrinolytic therapy when PCI is not available for appropriate patients with clinical and/or electrocardiographic evidence of ongoing ischemia within 12 to 24 hours of symptoms onset and a large area of myocardium at risk. Persistent chest pain after the onset of symptoms correlates with a higher incidence of collateral of anterograde flow in the infarct zone and is therefore a marker for viable myocardium that might be salvaged.